| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000021990 |
| Receipt No. | R000025342 |
| Official scientific title of the study | Assessment for the postgastrectomy syndrome |
| Date of disclosure of the study information | 2016/04/20 |
| Last modified on | 2016/04/19 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Assessment for the postgastrectomy syndrome | |
| Title of the study (Brief title) | Assessment for the postgastrectomy syndrome | |
| Region |
|
|
| Condition | ||
| Condition | Gastric cancer without distant metastasis | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate general and nutritional condition for the postgastrectomy patients. |
| Basic objectives2 | Others |
| Basic objectives -Others | Observational study |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Post operative Quality of Life. ( One month after, One year after) |
| Key secondary outcomes | Post operative nutritional condition. ( One month after, One year after) |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Histologically proven primary gastric cancer without distant metastasis | |||
| Key exclusion criteria | Metastasis to distant organ sites, other active concomitant malignancies, or recurrent gastric cancers. | |||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Shigeru Sasaki |
| Organization | Saitama Red Cross Hospital |
| Division name | Department of Surgery |
| Address | 8-3-33, Kamiochiai, Chuo-ku, Saitama city, Saitama |
| TEL | 048-645-1617 |
| shsasaki@saitama-med.jrc.or.jp | |
| Public contact | |
| Name of contact person | Shigeru Sasaki |
| Organization | Saitama Red Cross Hospital |
| Division name | Department of Surgery |
| Address | 8-3-33, Kamiochiai, Chuo-ku, Saitama city, Saitama |
| TEL | 048-645-1617 |
| Homepage URL | |
| shsasaki@saitama-med.jrc.or.jp | |
| Sponsor | |
| Institute | Saitama Red Cross Hospital, Department of Surgery |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Saitama Red Cross Hospital, Department of Surgery |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | さいたま赤十字病院(埼玉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Clinical stage of gastric cancer, Type of pathological character, Ages, Comorbidity, With or without chemotherapy, Type of operation and reconstruction, Operation time, Complications, PGSAS-45(PGSAS-37 + SF-8), Body Composition Analyze, etc. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025342 |